HER2/neu-directed therapy for biliary tract cancer

被引：0
|
作者：
Milind Javle
Chaitanya Churi
HyunSeon C. Kang
Rachna Shroff
Filip Janku
Rakesh Surapaneni
Mingxin Zuo
Christian Barrera
Humaid Alshamsi
Sunil Krishnan
Lopa Mishra
Robert A. Wolff
Ahmed O. Kaseb
Melanie B. Thomas
Abby B. Siegel
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine
[2] The University of Texas MD Anderson Cancer Center,Department of Diagnostic Radiology, Division of Diagnostic Imaging
[3] The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics, Division of Cancer Medicine
[4] Scott & White Clinic,Department of Radiation Oncology, Division of Radiation Oncology
[5] The University of Texas MD Anderson Cancer Center,Department of Gastroenterology
[6] The University of Texas MD Anderson Cancer Center,Departments of Medicine and Surgery
[7] Gibbs Cancer Center & Research Institute,undefined
[8] Columbia University,undefined
来源：
Journal of Hematology & Oncology | / 8卷
关键词：
Receptor; ErbB-2; Gallbladder neoplasms; Cancer of the biliary tract;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] HER2/neu-directed therapy for biliary tract cancer
    Javle, Milind
    Churi, Chaitanya
    Kang, HyunSeon C.
    Shroff, Rachna
    Janku, Filip
    Surapaneni, Rakesh
    Zuo, Mingxin
    Barrera, Christian
    Alshamsi, Humaid
    Krishnan, Sunil
    Mishra, Lopa
    Wolff, Robert A.
    Kaseb, Ahmed O.
    Thomas, Melanie B.
    Siegel, Abby B.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [2] HER2/neu-directed therapy for biliary tract cancer
    Al-Shamsi, Humaid Obaid
    Barrera, Christian Daniel
    Surapaneni, Rakesh
    Kang, HyunSeon
    Shroff, Rachna T.
    Janku, Filip
    Krishnan, Sunil
    Zuo, Mingxin
    Wolff, Robert A.
    Kaseb, Ahmed Omar
    Thomas, Melanie B.
    Siegel, Abby B.
    Javle, Milind M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Durable Remission under HER2/neu-directed Therapy with Trastuzumab and Pertuzumab in metastatic Gallbladder Cancer
    Czink, E.
    Heining, C.
    Glimm, H.
    Brors, B.
    Weber, T.
    Lasitschka, F.
    Schemmer, P.
    Schirmacher, P.
    Weiss, K.
    Weichert, W.
    Jaeger, D.
    Froehling, S.
    Springfeld, C.
    INTERNIST, 2016, 57 : S65 - S65
  • [4] HER2 status of biliary tract cancer
    Hiraoka, N.
    Yoshida, H.
    Nitta, H.
    Ohba, A.
    Morizane, C.
    Okusaka, T.
    VIRCHOWS ARCHIV, 2019, 475 : S216 - S216
  • [5] EGFR and HER2 expression in advanced biliary tract cancer
    Jan Harder
    Oliver Waiz
    Florian Otto
    Michael Geissler
    Manfred Olschewski
    Brigitte Weinhold
    Hubert E Blum
    Annette Schmitt-Graeff
    Oliver G Opitz
    World Journal of Gastroenterology, 2009, 15 (36) : 4511 - 4517
  • [6] EGFR and HER2 expression in advanced biliary tract cancer
    Harder, Jan
    Waiz, Oliver
    Otto, Florian
    Geissler, Michael
    Olschewski, Manfred
    Weinhold, Brigitte
    Blum, Hubert E.
    Schmitt-Graeff, Annette
    Opitz, Oliver G.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (36) : 4511 - 4517
  • [7] Therapeutic implication of HER2 in advanced biliary tract cancer
    Nam, Ah-Rong
    Kim, Ji-Won
    Cha, Yongjun
    Ha, Hyerim
    Park, Ji Eun
    Bang, Ju-Hee
    Jin, Mei Hua
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Han, Sae-Won
    Im, Seock-Ah
    Kim, Tae-You
    Oh, Do-Youn
    Bang, Yung-Jue
    ONCOTARGET, 2016, 7 (36) : 58007 - 58021
  • [8] Strategies to target HER2/neu overexpression for cancer therapy
    Chen, JS
    Lan, K
    Hung, MC
    DRUG RESISTANCE UPDATES, 2003, 6 (03) : 129 - 136
  • [9] RESULTS FROM TWO PHASE 1 TRIALS OF HER2/NEU-DIRECTED ACTIVE CELLULAR IMMUNOTHERAPY IN PATIENTS WITH ADVANCED MALIGNANCIES
    Sims, R. B.
    Park, J. W.
    Peethambaram, P. P.
    Melisko, M.
    Rinn, K. J.
    Alberts, S. R.
    Provost, N. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 99 - 99
  • [10] HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer
    Kim, Hongsik
    Kim, Ryul
    Kim, Hye Ryeon
    Jo, Hyunji
    Kim, Hana
    Ha, Sang Yun
    Park, Joon Oh
    Park, Young Suk
    Kim, Seung Tae
    FRONTIERS IN ONCOLOGY, 2022, 12
12345